Development and Evaluation of Floating-Mucoadhesive Dipyridamole Tablet


  • Maharashtra College of Pharmacy, Department of Quality Assurance, Nilanga, Maharashtra, 413521, India
  • NRI Institute of Pharmaceutical Science, Bhopal, M. P., India


The present study was aimed towards development and evaluation of tablet as a floating - Mucoadhesive drug delivery system, which can provide sustained release of the model drug. The work also was aimed to study various parameters affecting the behavior of floating - mucoadhesive tablet in oral dosage form. Formulation of Gastro - Retentive Dosage Forms (GRDFs) containing suitable drug candidate which would remain in stomach and/or upper part of GIT for prolonged period of time thereby is maximizing the drug release at desired site within the time before GRDFs leave the stomach and or upper part of GIT. Dipyridamole is BCS class II drug having low solubility and high permeability. It is soluble at low pH but insoluble in high pH (i.e. alkaline ph of small intestine )it s oral bioavailability is 37 - 66% & biological half life is also short (40 min). In this study the bioavailability of the dipyridamole increase by using various concentration of HPMC, Carbapol and Sodium bicarbonate for swelling, mucoadhesive and floating behavior respectively. Bioadhesive strength depends upon carbapol as concentration of polymer increases bioadhesive strength also increases. HPMC is water Swealable but Carbapol is hydrogel in nature it restricts movement of polymer and affect the swelling index .


Mucoadhesive, Floating, HPMC, Dipyridamole, Vasodilator Agent.

Subject Discipline

Pharmacy and Pharmacology

Full Text:


Amit kumar nayak gastro retentive drug delivery system Asian journal of pharmaceutical and clinical research vol 3 issue 1 2010, 2-10

shweta arora floating drug delivery system aaps phamscitech 2005 ;6(3) article 47 page 372-390 3. A V mayavanshi floating drug delivery system to incrses gastric retention of drug www.rjptonline org issn 0974 3618 page345-348

Arora S, Ali J, Khar RK, “Floating drug delivery System: A Review”, AAPS Pharm SciTech. (2005) 6(3), E372-E390.

Ross and Wilson, “Anatomy and Physiology in health and illness” 9th Edition, Churchill Livingstone, USA (1996) 295-297

Chawla G, Gupta P, Koradia V, Bansal A K. “Gastroretention a mean to address regional variability in intestinal drug absorption” Pharm tech. (2003) 50-68.

Garg, S., Sharma, S. “Gastro-retentive drug delivery system”, Pharm. Tech. (2003) 27, 50-68.

Wab H, Robinson JR, “Design of oral controlled release drug delivery systems”. In: Robinson VR, Lee VHL (editors). Controlled Drug Delivery Fundamentals and Applications, 2nd edition, New York: Marcel Dekker (1987) 418-420.

Atyabi F, Sharma HL,. “In vivo evaluation of a novel gastroretentive formulation based on ion exchange resins”. J. Control. Release, 1996; 42:105-13.

Shivakumar HG, Gowda DV,. ”Floating controlled drug delivery systems for prolonged gastric residence: a review”. Indian J Pharm Edu 2004; 38(4):172-8.

ikura h Suzuki y,nagani t,machid y oral sustend release pharmacutiacl preparation us patent 4,777,033(1988)oct 11

whitehead l,fell jt collet jh development of a gastroretantive doses form eur. J.pharm.sci.1996;4(suppl):s 182

kawashima y, niwa t, takeuchi h,hollow microsphere for use as a floating controlled drug delivery system in stomach j. Pharma sci. 1992,81,135-140

babu vbm, khar rk in vivo in vitro in vitro studies of sustained release floating doses form contanig salbutamol sulphatepharmzin 1990;45,268-270

S.u. Zategastro retentive bioadhesive drug delivery system international journal of pharmtech research coden (usa): ijprif issn : 0974-4304 vol.2, no.2, pp 1227-1235

Flávia Chiva Carvalho Mucoadhesive drug delivery systems Brazilian Journal of Pharmaceutical sciences vol. 46, n. 1, jan./mar., 2010

Sachan Nikhil K Basics and Therapeutic Potential of Oral Mucoadhesive Microparticulate Drug Delivery Systems International Journal of Pharmaceutical and Clinical Research 2009; 1(1): 10-14

Shaikh R, Raj Singh TR, Mucoadhesive drug delivery systems. J Pharm Bioall Sci2011;3:89-100

SAROJ KUMARROY Bioadhesive polymeric platform for transmucosal drug delivery system areview trop j pharm res feb 2010 ;9,(1)91,104.

Abubakar o.nur; Captopril floating and/or bioadhesive tablet: design and relies kinetics. Drug development an industrial pharmacy2000; 26(9):965-969.

Girish s.sonar; Bioadhesive-floating matrix tablet of salbutamol sulfate using response surface methodology. Journal of pharmacy research 2009:2(5):908-914.

Zawar Laxmikant R;Formulation And Evaluation Of Floating-Mucoadhesive Tablet Of Clarithromucin.International Journal Of Pharma And Bio Science 2010: V1(2):1-10

Mukopadhyay s, goswami; Formulation and evaluation of floating bioadhesive tablet of ciprofloxacine hydrochloride by direct compression technique. Ijpps 2010:vol 2,issue3,issn0975-1491:113-115

Mahesh d. Chavanpatil; novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin international journal of pharmaceutics, volume 316: 86-92

Manoj n.gambhire,kshitij w.ambade; Development and invitro evaluation of an oral floating matrix tablet of diltiazem hydrochloride; AAPS pharmascitecch 2007;8(3)

S ramakant; Formulation and characterization of floating tablet of Diltiazem HCl; journal of pharmacy research 2010 3(6) 1263-1267.

Jaleh varshosha: formulation and in vitro characterization of Ciprofloxacin floating bioadhesive extended release tablet. Drug delivery: 2006:13; 277-285.

H. R. Chueh; H. Zia,C. T. Rhodes :Optimization of Sotalol Floating and Bioadhesive Extended Release Tablet Formulations

Bhupinder singh; Formulation optimization of hydrodinamically balance oral control released bioadhesive tablet of tramadol HCl; scientia pharmaceuticals; 2010; 78:303- 323.

A.H.E kamel et al preparation and evaluation of Ketoprofen floating oral delivery system international jouranal of pharmaceutics

Raymond C.Rowe, Paul J.Sheskey and Sian C Owen, “Hand book of Pharmaceutical Excipients”, U.S.A, 4 th edn, 2000: 737-753

Raymond C.Rowe, Paul J.Sheskey and Sian C Owen, “Hand book of Pharmaceutical Excipients”, U.S.A, 4 th edn, 2000; 89-92.

C. V. S. Subrahmanyam. “Text Book of Physical Pharmaceutics”. 2nd edition. Delhi: Vallabh Prakashan.

; 210 – 28. al. self correcting monolithic floating matrix tablet of dipyridamol tablet of dipyridamol : influence of formulation variable.ijpsonline .com ip 59,90.142.112 page 219-225

viral f. patil statical evaluation of influence of viscosity and content of polymer on dipyridamol release from floating matrix tablet :atechnical note aaps pharmscitech 2007;8(3)article 69

Aulton M E. Pharmaceutics: The Science of Dosage Form Design. 2nd edition, Published by Churchill Livingstone, USA (1998) 223-253.

Martin A, Swarbrick J, Cammarata A. “Physical Pharmacy”, 3rd Ed, Varghese Publishing Company, Bombay, 1991, pp.492-52

The United State Pharmacopoeia. United state Pharmacopoeial Covenction, Rockville, MD .Asian Edn, 2000, 1941-3.

Banker GS and Anderson NR. Tablets. In: Lachman L, Lieberman H and Kanig JL. (eds.) The Theory and Practice of Industrial Pharmacy. Varghese Publishing House, Bombay (1998) 298-301

Garima Chawla “Gastroretention‟ A means to address regional variability in intestinal drug absorption” Pharmaceutical Technology, july 2003, p 50-58

Dave BS,et al. “Gastroretentive drug delivery system of Ranitidine hydrochloride: Formulation and in vitro evaluation” AAPS PharmSciTech 2004; 5 (2) Article 34

Uttam Mandal “Formulation and Optimization of SR matrix tablets of metformin Hcl using response surface methodology” the pharmaceutical society of Japan 127 (8) 1281-1290 (2007)


  • There are currently no refbacks.